covid
Buscar en
Angiología
Toda la web
Inicio Angiología Perfil lipídico de la macroangiopatía diabética. Un enfoque metabólico-hemod...
Journal Information
Vol. 52. Issue 6.
Pages 237-244 (January 2000)
Share
Share
Download PDF
More article options
Vol. 52. Issue 6.
Pages 237-244 (January 2000)
Full text access
Perfil lipídico de la macroangiopatía diabética. Un enfoque metabólico-hemodinámico
Lipid pattern of the diabetic macroangiopaty. A metabolic-hemodynamic approach
Visits
3415
María E. Triana Mantilla*, Alfredo Aldama Figueroa**, José I. Fernández Montequín***, Pedro González Amaro****, Olga Morejón Reinoso*****
* Licenciada en Bioquímica. investigador Titular Jeta del Laboratorio de Lípidos y Carbohidratos. Dpto. Bioquímica. INACV.
** Especialista de 2.º Grado en Fisiología Normal y Patológica. Dr. en Ciencias Médicas. Investigador Titular. Jefe del Dpto. de Hemodin´mica Vascular. INACV.
*** Especialista de 2.º Grado en Angiología y Cirugía Vascular. Servido de Angiopatía Diabética. Investigador Auxiliar. Director del INACV.
**** Especialista de 1.º Grado en Angiología y Cirugía Vascular. Servicio de Arteriología. INACV.
***** Técnico Laboratorio Clínico. Post-básico en Bioquímica. Dpto. Bioquímica. INACV.
This item has received
Article information
Resumen
Objetivos

Describir los patrones lipdídicos según el tipo de lesión vascular en pacientes con macroangiopatía diabética.

Materiales y Métodos

Se estudiaron 104 pacientes diabéticos (37 Tipo I y 67 Tipo II) y 27 pacientes no diabéticos con arterioesclerosis obliterante. Los diabéticos fueron divididos en 4 grupos (Normal, No ocluido, Ocluido y Ocluido-calcifi-cado), según la Clasificación Hemodinámica de la macroangiopatía diabética. Se cuantificaron o calcularon los niveles de CT, C-LDL, C-VLDL, C-HDL y TG.

Resultados

No se encontraron diferencias significativas en los patrones lipídicos de los distintos grupos de lesión vascular en los diabéticos Tipo l. Sin embargo, en los diabéticos Tipo II se hallaron perfiles lipídicos distintivos para cada tipo de lesión. El grupo Ocluido presentó un patrón lipídico similar al del grupo Ateroesclerótico, mientras que el grupo No ocluido se caracterizó por presentar niveles menores (p<0,05) de CT y de C-LDL y vatores mayores (p<0,05) de C-HDL con respecto al resto de los grupos. El grupo Normal presentó concentración elevadas pnrn todos los parámetros lipídicos (p<0,05) y una tendencia al aumento en el C-VLDL y TG.

Conclusiones

Los diabéticos Tipo II tienen perfiles lipídicos distintivos para cada tipo de lesión vascular. Los diabéticos con lesión vascular de tipo Ocluido, independientemente del tipo de DM, tiene un perfil lipídico similar al que presenta los ateroescleróticos.

Palabras clave:
Lípidos
lipoproteínas
diabetes mellitus
macroangiopatía diabética
complicación vascular
Summary
Objetive

To describe the lipid patterns according to the type of vascular lesion in patients with diabetic macroangiopathy.

Materials and methods

104 diabetic patients (37 type I and 67 type II) and 27 non diabetic subjects with obliterans atherosclerosis were studied. The diabetic ones were divided into 4 groups: Normal, Non Ocludcd, Occluded and Occluded with calcification taking into consideration the hemodynamic classification of the diabetic macroangiopathy. The levels of total cholesterol, LDL; VLDL; and HDL cholesterol and triglycerides were measured.

Results

No significant differences in the lipid profiles of the different groups of vascular lesion of type I diabetic subjects were found. However, distinctive lipid profiles for each type lesion were found in Type II diabetic patients. The Occluded group presented a lipid parameter similar to that of the atherosclerotic group, while the Non Occluded group was characterized by presenting lower levers of total cholesterol and LDL-chol. (p<0.05) and higher values of HDL-chol. (P<0.05) in relation to the othr groups. The normal group had a high concentration of total cholesterol (p<0.05) regarding the atherosclerotic group.

Conclusions

There are characteristic lipid profiles for each type of vascular lesion in patients with Type II. The diabetic subjects with vascular lesion Occluded type show a lipid profile similar to that of the atherosclerotic patients irrespective of the type of diabetes mellitus.

Key words:
Lipids
lipoproteins
diabetes mellitus
diabetic macroangiopathy
vascular complication
Full text is only aviable in PDF
Bibliografía
[1.]
Lundbaek K..
Blood vessel disease.
Acta Diabetol., 8 (1971), pp. 3-4
[2.]
Leutinegger M., Bertin E..
Diabetes Mellitus and Atherosclerosis. Physiology of diabetic macroangiopathy.
Esv. Med. Interne., 16 (1995), pp. 31-42
[3.]
Andressen J.L., Rasmussen L.M., Ledet T..
Diabetic macroangiopathy and Atherosclerosis.
Diabetes, 45 (1996), pp. 91-94
[4.]
Capron L..
Mechanisms of diabetic macrovascular lesions.
Diabetes Metab., 20 (1994), pp. 357-361
[5.]
Donahue R.P., Orchard T.J..
Diabetes Mellitus and macrovascular complications. An epidemiological perspective.
Diabetes Care, 215 (1992), pp. 1145-1155
[6.]
Nathan D.M..
The pathophysiology of diabetic complications: how much does. The glucose hyphothesis explain?.
Ann. Intern. Med., 124 (1996), pp. 86-89
[7.]
Albrrink M.J., Lavietes P.H., Mann E.B..
Vascular Diseases and serum lipids in diabetes mellitus: observation of 30 years.
Ann. Intern. Med., 8 (1963), pp. 305-323
[8.]
Zimmerman B.R., Palumbo P.J., O Fallon W.M., Elleton R.D., Ossmundson P.J., Kazmier F.J..
A prospective study of periferal occlusive arterial disease diabetes. Ill Lipid and Lipoproteins finding.
Mayo Clin. Proc, 56 (1981), pp. 233-242
[9.]
Aldama-Figueroa A., Vega M., Ley J., Fern´ndez J., Lima B., Alvarez H., Montalvo J., Carvajal F..
Haemodynamic classification of diabetic macroangiopathy.
Journal Vascular Investigation, 4 (1998), pp. 171-174
[10.]
Ley J., Alvarez J.A., Vega M.E..
Técnicas ultrasónicas. En Hemodinámica Vascular. Ciudad Habana.
Ciencias Médicas, (1986), pp. 45-73
[11.]
Burstein M., Scholniak H.R., Worfin R..
Rapid method for the isolation of lipoprotein from human serum by precipitation with polyanions.
J. Lipid. Res., 11 (1970), pp. 583-595
[12.]
Fkiedewald W.T., Levy R.I., Fredickson D.S..
Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge.
Clin. Chem., 18 (1972), pp. 499-502
[13.]
Trivielle L.A., Ranne T.H.M., Lay H.T..
Haemoglobin components in patients with diabetes mellitus.
N. Engl. J. Med., 284 (1971), pp. 353-357
[14.]
Nathan D.M..
The pathophysiology of diabetic complications: how does the glucose hypothesis explain?.
Ann. Intern. Med., 124 (1996), pp. 86-89
[15.]
Klein R., Klein B.E.K., Moss S.E..
Relation of glycemic control to diabetic microvascular complications in diabetes mellitus.
Ann. Intern. Med., 124 (1996), pp. 90-96
[16.]
Laakso M..
Glicemic control and the risk for coronary heart disease in patients with non insulin dependent diabetes mellitus.
Ann. Intern. Med., 124 (1996), pp. 127-130
[17.]
Fontbonne A., Eschwege M..
Diabetes, hyperglycacmia, hyperinsulinaemia and atherosclerosis. Epidemiological data.
Diabetes Metab., 13 (1987), pp. 350-353
[18.]
Ginsberg H.N..
Lipoprotein physiology in non diabetic and diabetic states: relationship to atherogenesis.
Diabetes Care, 4 (1991), pp. 839-855
[19.]
Ikeda T..
Serum lipid and lipoprotein levels in non hypertensive man NIDDM patients.
J. Intern. Med., 230 (1991), pp. 131-134
[20.]
Steiner G..
Dyslipoproteinemias in diabetes.
Clin, Invest. Med., 18 (1995), pp. 282-287
[21.]
Ninomiya K., Maruhama Y..
Plasma fatty acids, lipids, lipoprotein and macroangiopathy.
Rinshobyori, 43 (1995), pp. 449-453
[22.]
Gordon T..
High density lipoprotein as a protective factors against coronary heart disease. The Framighan study.
Am. J. Med., 62 (1977), pp. 707-714
[23.]
Miller G.J..
High density lipoproteins and atherosclerosis.
Ann. Rev. Med., 31 (1980), pp. 97-108
[24.]
Glomset J.A..
High density lipoproteins in human health and disease.
Adv. Intern. Med., 29 (1980), pp. 91-116
[25.]
Nikkilá E.A..
High density lipoproteins in diabetes.
Diabetes, 30 (1981), pp. 82-87
[26.]
Colwell J.A., Lopes-Virella M.F..
A review of the development of large vessel disease in diabetes mellitus.
Am. J. Med., 85 (1988), pp. 113-118
[27.]
Chen Y.D.I., Jeng C.Y., ReaVen E.M..
Hdl metabolism in diabetes.
Diabetes Metab., 3 (1987), pp. 653-668
[28.]
Brown W.V..
Lipoprotein disorders in diabetes mellitus.
Med. Clin. North Am., 78 (1994), pp. 43-61
[29.]
Tasklnen M.R..
Diabetic dislipidemia in NIDDM.
International Diabetes Monitor, 3 (1996), pp. 1-7
[30.]
Triana M.E., Simón R., Cardona M., Fernández J.I., Lima, Castro H.M..
Metabolismo lipídico. Angiopatía Diabética dos membros inferiores.
Rev. Bras. de Flebol. e Linfología, 4 (1997), pp. 15-21
[31.]
Beck-Nieisen H., Henriksen J.E., Vaag A..
Pathophysiology of non insulin dependent diabetes mellitus (N1DDM).
Diabetes Res. Clin. Pract., 28 (1995), pp. 13-25
[32.]
O'Brien T., Nguyen T.T., Zimmerman B.R..
Hyperlipemia and Diabetes Mellitus.
Mayo Clin. Proc., 73 (1998), pp. 969-976
Copyright © 2000. SEACV
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos